Publications by authors named "Mervyn Tyrer"

Claim this Profile
D
Detection of low-frequency K103N mutants after unstructured discontinuation of efavirenz in the presence of the CYP2B6 516 TT polymorphism.
Ana Garcia-Diaz, Chun Bong Lok, Sara Madge, Clare Booth, Mervyn Tyrer

J Antimicrob Chemother· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stability of antiretroviral regimens in patients with viral suppression.
Rebecca K Lodwick, Colette J Smith, Mike Youle, Fiona C Lampe, Mervyn Tyrer

AIDS· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Success of clinical care for human immunodeficiency virus infection according to demographic group among sexually infected patients in a routine clinic population, 1999 to 2004.
Fiona C Lampe, Colette J Smith, Sara Madge, Sabine Kinloch-de Loes, Mervyn Tyrer

Arch Intern Med· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pseudomonal sepsis with subcutaneous nodules in an HIV-infected individual with high CD4 counts.
Shema Tariq, Saira Hameed, Mervyn Tyrer, Margaret Johnson, Marc Lipman

J Infect· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The relationship between CD4 cell count nadirs and the toxicity profiles of antiretroviral regimens.
J Smith Colette, Caroline A Sabin, Fiona C Lampe, Sapna Shah, Mervyn Tyrer

Antivir Ther· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kaposi's sarcoma-associated herpesvirus cytotoxic T lymphocytes recognize and target Darwinian positively selected autologous K1 epitopes.
Justin Stebbing, Dimitra Bourboulia, Margaret Johnson, Stephen Henderson, Ian Williams, Mervyn Tyrer

J Virol· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Viral breakthrough after suppression with highly active antiretroviral therapy: experience from 233 individuals with viral loads of less than 50 copies/ml followed for up to 4 years.
Fiona C Lampe, Margaret A Johnson, Marc Lipman, Clive Loveday, Mike Youle, Mervyn Tyrer

AIDS· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Raised viral load in patients with viral suppression on highly active antiretroviral therapy: transient increase or treatment failure?
Antonia L Moore, Mike Youle, Marc Lipman, Alessandro Cozzi-Lepri, Fiona Lampe, Mervyn Tyrer

AIDS· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brief report: two-year outcome of a multidrug regimen in patients who did not respond to a protease inhibitor regimen.
Mike Youle, Mervyn Tyrer, Martin Fisher, Fiona Lampe, Deborah Wilson

J Acquir Immune Defic Syndr· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis